Cravacin (Deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Recommended Dosages
Contraindication
CRAVACIN is contraindicated in patients with a history of hypersensitivity reaction to deucravacitinib or to any of the excipients in CRAVACIN.
Limitations of Use
CRAVACIN is not recommended for use in combination with other potent immunosuppressants.